Although resistance to therapy is commonly associated to the more aggressive mesenchymal phenotype, it was previously demonstrated that the unbalance between RAS/MAPK and PI3K/AKT signaling in favor of the latter decreases the EMT potential in cancer cells, even in presence of EMT inductors such as Snail [32]. This evidence concerns the gene AKT1 and cancer.